推荐产品
产品名称
JNK抑制剂II, JNK Inhibitor II. SP600125, CAS 129-56-6, is a potent, cell-permeable, selective, and ATP competitive inhibitor of c-Jun N-terminal kinase (JNK; IC₅₀ = 40 nM for JNK-1 & JNK-2 & 90 nM for JNK-3).
品質等級
描述
RTECS - CB4585000
化驗
≥98% (HPLC)
形狀
solid
製造商/商標名
Calbiochem®
儲存條件
OK to freeze
protect from light
顏色
yellow-orange
溶解度
DMSO: 15 mg/mL
運輸包裝
ambient
儲存溫度
−20°C
SMILES 字串
[nH]1nc2c3c1[c]4[c]([c]([c]3=CC=C2)=O)=CC=CC=4
InChI
1S/C14H8N2O/c17-14-9-5-2-1-4-8(9)13-12-10(14)6-3-7-11(12)15-16-13/h1-7H,(H,15,16)
InChI 密鑰
ACPOUJIDANTYHO-UHFFFAOYSA-N
一般說明
一种有效的,细胞可渗透的,选择性并可逆的c-Jun N末端激酶(JNK)抑制剂(JNK-1和JNK-2的IC50 = 40 nM,JNK-3的IC50=90 nM)。这种抑制对于ATP具有竞争性。与ERK1和p38-2 MAP激酶相比,对JNK的选择性高300倍以上。抑制c-Jun的磷酸化,阻断IL-2、IFN-γ、TNF-α、COX-2的细胞表达。阻断IL-1诱导的磷酸化-Jun积累和c-Jun转录的诱导。也可使用50 mM(5 mg/454 µl)JNK抑制剂II(目录号420128)的DMSO溶液。
生化/生理作用
主要靶标
JNK 1,JNK 2,JNK 3
JNK 1,JNK 2,JNK 3
产物与ATP竞争。
可逆性:是
细胞可渗透性:是
靶标IC50:40 nM,对于JNK-1和JNK-2;90 nM,对于JNK-3
包裝
用惰性气体包装
警告
毒性:标准处理(A)
準備報告
对于每10 µM浓度的JNK抑制剂II,在培养基中应包含0.1%DMSO。培养基的预热和向培养基中添加BSA可能会增强其溶解度。
重構
复溶后,等分并在-20°C下冷冻保存。储备溶液在-20°C下可稳定保存2个月。
其他說明
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Hu Xu et al.
American journal of physiology. Heart and circulatory physiology, 300(3), H913-H921 (2010-12-28)
High-mobility group box 1 (HMGB1) is a nuclear protein that has been implicated in the myocardial inflammation and injury induced by ischemia-reperfusion (I/R). The purpose of the present study was to assess the role of HMGB1 in myocardial apoptosis induced
Wenjuan Sun et al.
Frontiers in pharmacology, 13, 807452-807452 (2022-05-03)
Inflammation and apoptosis are the major contributors to the mechanisms of acute kidney injury (AKI) due to renal ischemia-reperfusion injury (IRI). Maslinic acid (MA), a pentacyclic triterpene acid mostly found in dietary plants, the current study was to demonstrate the
Viviana Diaz-Aguirre et al.
Cell biology international, 40(11), 1162-1173 (2016-08-04)
Whether fructose (FRU), as the sole energy source, confers a metabolic advantage on cancer cells against noxious stimuli is unknown. The aim of this study was to evaluate the effects of low (11 mM), moderate (25 mM), and high (55 mM) FRU concentrations
Chongyun Cheng et al.
ACS omega, 7(16), 13925-13931 (2022-05-14)
The c-Jun N-terminal kinases (JNKs) are evolutionary highly conserved serine/threonine kinases. Numerous findings suggest that JNK3 is involved in the pathogenesis of neurodegenerative diseases, so the inhibition of JNK3 may be a potential therapeutic intervention. The identification of novel compounds
Dai-Xu Li et al.
General physiology and biophysics, 39(6), 545-555 (2020-11-24)
Cardiovascular disease (CVD) states are associated with endothelial dysfunction (ED) and increased production of ROS in endothelial cells. The present study aimed to explore the protective effects of antioxidant protein peroxiredoxin 6 (PRDX6) on angiotensin II (AngII)‑induced human umbilical vein
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门